Loss Per Share

9 Months Ended

Dec. 31, 2019

The following summarizes the computation of loss per share:


	Three Months Ended December 31,						Nine Months Ended December 31,
(in thousands, except per share data)	2019		2018		2019		2018
Basic loss per share:
Net loss attributable to Pyxus International, Inc.	$	(21,993)	$	(5,095)	$	(100,308)	$	(60,487)
Shares:
Weighted average number of shares outstanding⁽¹⁾	9,166		9,068		9,137		9,048
Basic loss per share	$	(2.40)	$	(0.56)	$	(10.98)	$	(6.69)

Diluted loss per share:
Net loss attributable to Pyxus International, Inc.	$	(21,993)	$	(5,095)	$	(100,308)	$	(60,487)
Shares:
Weighted average number of shares outstanding⁽¹⁾	9,166		9,068		9,137		9,048
Plus: Restricted shares issued and shares applicable to stock options and restricted stock units, net of shares assumed to be purchased from proceeds at average market price⁽²⁾	—		—		—		—
Adjusted weighted average number of shares outstanding	9,166		9,068		9,137		9,048
Diluted loss per share	$	(2.40)	$	(0.56)	$	(10.98)	$	(6.69)
(1) 785 shares of common stock were owned by a wholly owned subsidiary as of December 31, 2019 and 2018.
(2) Outstanding restricted shares, shares applicable to stock options, and restricted stock units are excluded because their inclusion would have an antidilutive effect on the loss per share. The dilutive shares would have been 10 and 66 for the three months ended December 31, 2019 and 2018, respectively, and 28 and 62 for the nine months ended December 31, 2019 and 2018, respectively.

Certain potentially dilutive options were not included in the computation of loss per diluted share because their effect would be antidilutive. Potential common shares are also considered antidilutive in the event of a net loss. The number of potential shares outstanding that were considered antidilutive and that were excluded from the computation of diluted loss per share, weighted for the portion of the period they were outstanding were as follows:


	Three Months Ended December 31,						Nine Months Ended December 31,
	2019		2018		2019		2018
Antidilutive stock options and other awards	452		427		450		427
Antidilutive stock options and other awards under stock-based compensation programs excluded based on reporting a net loss for the period	—		—		—		—
Total common stock equivalents excluded from diluted loss per share	452		427		450		427
Weighted average exercise price	$	56.66	$	60.00	$	56.98	$	60.00